Tag Archives: VBI

[ad_1] Thinly traded micro cap VBI Vaccines (NASDAQ:VBIV) is up 15% premarket on light volume in apparent reaction to its announcement that initial data from its Phase 1/2a clinical trial evaluating VBI-1901 in recurrent …

[ad_1] CAMBRIDGE, Mbad., July 9, 2018 (GLOBE NEWSWIRE) – VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial biopharmaceutical company developing next-generation vaccines against infectious and immuno-oncological diseases , announced today that the …